Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Big Pharma's Key Lifecycle Management Strategies Maximizing The Market Potential |
Feb 2010 | £2,215 | 100% |
| World Pharma Contract Sales Organisation (CSO) Market 2011-2021 |
Sep 2011 | £1,699 | 99% |
| Strategies and Solutions for Publication Planning and Execution Excellence | Sep 2007 | £75 | 98% |
| Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing 3rd Edition |
Jan 2009 | £2,215 | 98% |
| Sales Force Effectiveness in Pharmaceuticals Cost Pressures Increase Pharmaceutical Companies' Adoption of New Sales Models and Technologies |
Oct 2010 | £2,215 | 98% |
| Online Marketing and eDetailing | Jul 2006 | £75 | 96% |
| Pharmaceutical Contract Sales Organizations (CSO) Emerging Markets to Drive Growth but Talent Acquisition in Specialty Secondary Care Remains a Challenge |
Aug 2010 | £2,215 | 95% |
| The Outlook for Pharmaceuticals Worldwide | Jan 2012 | £9,995 | 95% |
| Biotechgate Company Database A comprehensive life sciences information source |
Jun 2011 | £995 | 93% |
| Fondaparinux sodium Comprehensive Patent Search |
Jun 2011 | £4,150 | 93% |
| How Drugs Are Developed 3rd Edition |
Jan 2007 | £1,095 | 92% |
| Market Access Brazil Unlocking Pharma Potential |
Jul 2011 | £555 | 91% |
| Disease Management and Drug Adherence: Strategies to support patients and enhance treatment persistence | Jul 2007 | £4,805 | 91% |
| Omega-3-acid ethyl esters Comprehensive Patent Search |
Jun 2011 | £6,105 | 90% |
| Building Strong Market Access Teams | Feb 2011 | £395 | 90% |
| Online Marketing and eDetailing Europe | Jul 2007 | £75 | 90% |
| Creating compelling market access stories | Aug 2011 | £355 | 89% |
| Takeda Pharmaceutical Co., Ltd PharmaVitae Profile |
Oct 2010 | £3,605 | 89% |
| Stakeholder Opinions: Type 2 Diabetes in the UAE & Saudi Arabia Growth opportunities in fragmented markets |
Dec 2008 | £2,405 | 88% |
| Pharma Marketing Excellence Lessons from Experience |
Aug 2011 | £415 | 88% |
| Lifesciences IT 2011 Yearbook |
Jun 2011 | £2,215 | 88% |
| Aspreva Pharmaceuticals Corporation Premium Company Profile |
Nov 2007 | £170 | 88% |
| CNS Therapeutics A World Market Review |
Nov 2009 | £1,895 | 88% |
| Top 10 Healthcare Trends in 2011 | Mar 2011 | £2,215 | 88% |
| Pharmaceutical Research and Development (R&D) Increasing Efficiency through Information Technology and Externalization |
May 2010 | £2,215 | 88% |
| Premium Company Profile Savient Pharmaceuticals | Oct 2007 | £315 | 88% |
| Strategies for Managing Pharmaceutical Workforce and Site Reductions Analysis of legal, productivity, and quality control issues |
Aug 2010 | £2,425 | 88% |
| Chronic Pain Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
Apr 2011 | £1,265 | 87% |
| Pharmaceutical Pricing Compendium A practical guide to the pricing and reimbursement of medicines |
Mar 2003 | £125 | 87% |
| Commercial Insight: Antihormonal Cancer Therapies | Jul 2009 | £9,615 | 87% |
